An interleukin 1a (IL-1a) cDNA probe and an IL-l responsive T-cell clone (D1O.G4; half-maximal stimulation, 0.1-1 pM) have been used to study the production of IL-1 by primary murine cell populations, particularly macrophages and dendritic cells. Spleen and peritoneal macrophages produced IL-1 mRNA and released biologically active IL-1 when challenged with lipopolysaccharide (LPS). Induction of IL-1 was evident over a dose range of 0.01-10 ,jg of LPS per ml, and maxmal mRNA levels were maintained from 4 to 20 hr. Several other stimuli did not induce IL-1 in cultured macrophages, including phorbol 12-myristate 13-acetate, r-interferon, Con A, macrophage colony-stimulating factor, IL-3, cachectin, and activated T cells. Activated T cells could markedly reduce the response ofperitoneal macrophages to LPS. When other cell types were compared with macrophages, keratinocytes had high levels of IL-1 mRNA, apparently in response to endogenous LPS. However B and T lymphocytes did not yield detectable IL-1 during proliferative responses to LPS and Con A, respectively, While dendritic cells produced little or no IL-1 when challenged with a battery of stimuli. Therefore, IL-1 may not be required for the potent accessory function of dendritic cells in lymphocyte mitogenesis. The results indicate that macrophages and dendritic cells have different secretory capacities. The macrophage is the principal leukocyte that synthesizes IL-1, and select stimuli increase and decrease the levels of macrophage IL-1 mRNA.
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Interleukin 1 (IL-1) is a 16-kDa polypeptide that mediates several aspects of acute and chronic inflammation (1) . The events that are influenced by IL-1 include synthesis of acute phase proteins by hepatocytes, release of degradative enzymes from connective tissue cells, and proliferation of lymphocytes (1) . Among the leukocytes, macrophages, lymphocytes, and dendritic cells have all been implicated in production of IL-1 (2) (3) (4) (5) (6) (7) (8) .
RNA blotting and a sensitive IL-1 bioassay have recently become available to study the production of IL-1. We have used these assays on primary cell populations with an emphasis on a comparison of macrophages and dendritic cells. These leukocytes have different roles in cell-mediated immunity. The macrophage functions as an effector cell in phagocytosis and anti-microbial resistance, while the nonphagocytic dendritic cell acts as a potent, if not essential, accessory cell for induction of antigen-specific sensitized T lymphocytes (9) (10) (11) . The capacity of these two cell types to synthesize cytokines such as IL-1 has not been compared in detail. We report that macrophages, but not dendritic cells, make IL-1, and we define some of the stimuli that increase and decrease the levels of macrophage IL-1 mRNA.
MATERIALS AND METHODS
Mice. BALB/c X DBA/2 (C x D2)F1, B6.H-2k, ICR, C3H/He (The Trudeau Institute, Saranac Lake, NY), and BALB/cAnN (The Rockefeller University) mice of both sexes were used with similar results.
Medium. RPMI 1640 medium (GIBCO) was supplemented with 10% heat-inactivated fetal calf serum (Sterile Systems, Logan, UT)/1 mM glutamine/streptomycin (10 ,ug/ml)/penicillin (100 units/ml)/gentamycin (20 gg/ml)/50 ,4M 2-mercaptoethanol.
Cytokines. Murine recombinant IL-1,a (rIL-la) [specific activity, 6 x 106 units/mg in the standard thymocyte mitogenesis assay (12) ] was provided by P. Lomedico (Hoffmann-La Roche). Murine recombinant y-interferon (rIFN-y) (6 x 106 units/mg) was provided by Genentech (South San Francisco, CA), and human recombinant cachectin/tumnor necrosis factor (108 units/mg) was from B. Beutler and A. Cerami (The Rockefeller University). Conditioned media from the'WEHI-3 cell line and L cells were used as sources of IL-3 and macrophage colony-stimulating factor, respectively.
Lipopolysaccharide (LPS). Boivin preparations of Escherichia coli 05:B55 and Salmonella typhosa LPS were from Difco. Purified LPS from E. coli K-12, rough mutant 94 mm, was from List Biological Labs (Campbell, CA).
IL-1 Bioassay. The D10.G4.1 T cell clone was passaged as described (13) . A standard curve was constructed relating D10 growth to rIL-1 dose (units determined in the thymocyte assay). This curve was related to the dose-response curve of various samples. Half-maximal stimulation of D10 cell growth was observed at 0.01-0.1 unit of rIL-la per ml (0. (106) were cultured in 1 ml of medium in 16-mm diameter wells with or without LPS (10 Ag/ml). Graded doses of culture supernatant were assayed for activity in the D10 bioassay (see Fig. 4 for standard curves and assay conditions). *Sample in which the IL-1 level was less than half-maximal (-0.01 unit of rIL-1 per ml) at 10% (vol/vol).
per Ag of DNA. Blots were hybridized overnight with 106 cpm/ml and washed as described (15 (Fig. LA Left) . The mRNA was a single 2.6-kilobase (22S) message that comigrated with the IL-1a mRNA from the LPS-induced macrophage cell line J774. mRNA was detectable at 1 hr (not shown), maintained plateau levels for 4-20 hr, and decreased markedly by 48 hr (Fig. LA) . LPS from S. typhosa and purified LPS from an E. coli strain K-12 rough mutant had comparable IL-1 inducing activity with plateau levels of mRNA at 10 ng/ml (Fig. 1B) . Polymyxin B, a cyclic peptide that binds and neutralizes LPS, reduced the IL-1-inducing activity of LPS -100-fold but did not alter macrophage viability, total RNA yield, or actin mRNA levels (not shown). [3H]Thymidine uptake of 30,000 T blasts plus 10,000 macrophages was 98,000 cpm after exposure to 4 MCi/ml at 24-32 hr. When present, the LPS dose was 10 ,ug/ml. RNA was extracted from the adherent (shown) and nonadherent (not shown, but IL-1 mRNA was not detectable) layers and 5 ,ug of RNA was loaded per lane.
LPS stimulated B cells to proliferate actively but did not induce IL-l1a mRNA (Fig. 1A Right) confirmed with the D10 bioassay, which showed that macrophages released high levels of IL-1, while B and T cell populations were essentially inactive (Table 1) . Whereas IL-1a mRNA reached plateau levels 4 hr after addition of LPS to macrophages (Fig. 1A) , the cytokine was just detectable in the medium at that time ( Table 1) .
Comparison of LPS with Other Stimuli. A large number of agents have been considered to be active in inducing IL-1 (1). Many proved to be weak or inactive when tested on primary peritoneal (Fig. 2) and spleen (see below) macrophages. The stimuli included Con A, phorbol 12-myristate 13-acetate (PMA), and IFN-y either alone or in combination ( Fig. 2A) (Fig. 2B) , the conditioned medium from Con A-stimulated rat spleen cells (data not shown) and rIFN-y (Fig. 2C) , and alloreactive T lymphoblasts (Fig. 2C) . In the macrophage-T-cell coculture experiments (Fig. 2 B  and C) , we observed clustering of the two cell types and significant T-cell proliferation (Fig. 2, legend) but little or no IL-1 mRNA. Remarkably, the addition of alloreactive T blasts reduced the level of IL-1 mRNA in response to LPS but had no effect on cell viability or actin mRNA levels (Fig. 2C) . We did not assay the macrophage-T-cell medium for IL-1 biologic activity, since the D10 cell line would respond to the IL-2 that was released by the stimulated lymphocytes. We conclude that LPS is the principal agent that induces IL-1 in mouse peritoneal macrophages, while sensitized T cells can reduce the LPS effect.
Comparison of Spleen Macrophages and Spleen Dendritic Cells. Adherent spleen cells contain Fc receptor negative dendritic cells and Fc receptor positive macrophages and B lymphocytes. The former induce T-cell responses to several antigens in vitro and in vivo (9) (10) (11) 19) . Spleen adherent cells, like peritoneal cells, could be induced to express IL-1 mRNA by LPS (Fig. 3) after LPS stimulation, the latter synthesized IL-1 mRNA (Fig. 3) . The trace amount of IL-1a mRNA in the Fc receptor negative dendritic cell-enriched fraction could be attributed to residual macrophages (<3% ofthe total cells). Since spleen B cells did not produce IL-1 (Fig. 1, Table 1 ), the active Fc receptor positive cell was likely the macrophage.
The dendritic cell-and macrophage-enriched fractions of spleen-adherent cells were stimulated with a variety of individual cytokines, PMA, or LPS. When the conditioned medium was tested for IL-1 in the sensitive D10 bioassay, only macrophages released active IL-1 when exposed to LPS but not other stimuli (Fig. 4) . Dendritic cells did not release IL-1 (Fig. 4) , and frozen-thawed lysates of dendritic cells lacked activity (not shown). When unfractionated adherent cells were treated with monoclonal antibody 33D1 and complement to deplete dendritic cells (9) , the production of IL-1 in response to LPS was not reduced (not shown). Thus, IL-1 primarily is a macrophage rather than a dendritic cell product.
IL-1 mRNA Expression in Keratinocytes. Epidermal cells release a cytokine that is similar to IL-1 (20) . Keratinocyte monolayers that were depleted of Ia positive dendritic cells were prepared (18) and analyzed for IL-1a mRNA. Keratinocytes from (C x D2)F1 mice had significant levels of IL-1 mRNA. The amounts increased slightly upon addition of LPS. Since exposure to LPS (from the Gram-negative bacteria in mouse skin) during the preparation of epidermal cell suspensions was likely, we asked if cells from LPS unresponsive C3H/HeJ mice also had IL-1. None was found, and no response to LPS was observed (Fig. 5) The stimuli for macrophage IL-1 gene expression seem quite restricted, however. LPS is such a potent inducer (Fig.  1B) that the presence of small numbers of macrophages or small amounts of LPS severely complicates the analysis of IL-1 inducing stimuli and responsive primary cells. Con A, PMA, macrophage colony-stimulating factor, IL-3, IFN-y, cachectin, and T cells do not trigger spleen and peritoneal macrophages (Figs. 2 and 4) . Since we have only studied cultured tissue macrophages, some ofthe inactive agents may stimulate other populations of mononuclear phagocytes such as the blood monocyte. We also note little or no IL-1 mRNA (experiments not shown) in peritoneal macrophages elicited by periodate, thioglycollate, or bacillus Calmette-Gudrin mycobacteria in situ (at day 5, the height of the inflammatory response).
The effect of T cells on the induction of IL-1 is under further study. A subpopulation of T cells, or a particular developmental stage of the macrophage such as the blood monocyte, may be required to observe IL-1 induction. This possibility is being pursued with human blood monocytes and a rabbit anti-IL-i antibody to identify individual monocytes with IL-1 (22) . The mixing of sensitized T cells with macrophages can clearly reduce IL-1ia mRNA (Fig. 2C) . It remains to be determined whether this inhibition is due to a soluble T-cell factor.
Our results question the need for IL-1 in lymphocyte activation. B cells proliferating in response to LPS, and T lymphocytes proliferating in association with macrophages, do not necessarily produce the cytokine (Figs. iA and 2 B and C). Dendritic cells, which are active accessory cells for a variety ofT-dependent immune responses (9-11), also do not appear to make IL-1 (Figs. 3 and 4) . Exogenous rIL-i has little direct effect on T cells even in the presence of lectin or antigen (13) . Therefore, IL-1 may not be essential for lymphocyte mitogenesis. Recent experiments indicate that IL-1 amplifies the capacity of dendritic cells to stimulate T cells (13) . This amplification may account for some ofthe previous observations on the lymphocyte-activating properties of this cytokine.
